Single Rising Dose (SRD), Multiple Rising Dose (MRD) Study of BI 671800 in Healthy Asian Volunteers

NCT01216384 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

73

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma
Rhinitis, Allergic, Perennial

Interventions

DRUG: BI 671800
DRUG: placebo

Sponsor

Boehringer Ingelheim